Skip to main content

    Main navigation

    • Investors
    • About
    • News
    • Contact us
    • Egoo.health
    • en
    • sv
Home

Main navigation

  • Investors
  • About
  • News
  • Contact us
  • Egoo.health
  • en
  • sv
 

Investors

+

Main navigation

Main navigation

  • News - Press releases
  • Financial Calendar
  • Financial reports
    • IPO and listning documents
  • Corporate governance
    • Articles Of Association
    • AGM and Extraordinary general meetings
      • Annual General Meeting on May 5 2022
      • Annual general meeting on 5 May 2021
      • Extraordinary Shareholders Meeting 19 November
      • Extraordinary general meeting January 2020
      • Annual General Meeting, May 20, 2020
    • Auditor
    • Nomination Committee
    • Certified adviser
  • Share information
    • Major shareholders
    • Sharecapital
    • Incentive programme
    • Dividend Policy
    • Warrants (TO)
  • Board
  • Management
  • Insiders
  • IR Contact
  • Presentations

Annual General Meeting, May 20, 2020

Notice to the annual shareholders meeting

Power of Attorney

Förslag till beslut om emissionsbemyndigande

Förslag till beslut om ändring av bolagsordningen

Instruktion och arbetsordning för valberedningen

Qlife

Qlife Holding AB
Redaregatan 48
SE-252 36 Helsingborg, Sweden
info@egoo.health

Links

  • About
  • Investors
  • Egoo.health

Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarker and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information that can contribute to better treatment and potential prevention of diseases is facilitated. On March 2, 2020, Qlife Holding completed a listing on the Nasdaq First North Growth Market, Stockholm. The company currently has about 40 employees.